Key Takeaways
- AXT has priced a public equity offering at $64.25 per share, seeking to generate up to $632.5 million with full underwriter participation
- Shares fell approximately 12% during Tuesday’s premarket session after the capital raise disclosure
- First quarter revenue projections stand at $26M–$28M, representing growth from $19.4M year-over-year, though net losses of $1.6M–$2.6M are anticipated
- Capital raised will support expanded production capabilities at Beijing Tongmei for indium phosphide substrates
- The pullback marks a notable correction following an extraordinary 5,867% climb over the trailing twelve months
AXT Inc. (AXTI) has delivered one of the most spectacular performances in the equity markets over the past year. The compound semiconductor company’s staggering 5,867% surge across twelve months represents a rare feat. However, Tuesday morning introduced significant volatility, with shares retreating approximately 12% in premarket action following the disclosure of a substantial stock offering.
Premarket quotes showed the stock changing hands near $69.43, marking a decline from the previous session’s close that had valued the company at $4.38 billion in market capitalization.
Northland Securities is underwriting the offering, which carries a price of $64.25 per share. The semiconductor materials company is issuing 8,560,311 common shares, while granting underwriters a 30-day greenshoe option for an additional 1,284,046 shares. The base transaction is projected to yield approximately $550 million, potentially reaching roughly $632.5 million should underwriters exercise their full allotment. Transaction completion was scheduled for April 22.
According to AXT, the capital will predominantly fund operations at Beijing Tongmei Xtal Technology, its subsidiary specializing in indium phosphide substrate manufacturing for global export markets. Remaining funds are allocated toward research and development initiatives, working capital requirements, and general corporate operations.
The company’s executive leadership team and board members have committed to a 60-day lock-up period on their equity holdings beginning with the prospectus supplement date.
The Strategic Importance of Indium Phosphide
Indium phosphide substrates serve as critical components in optical networking equipment deployed throughout data center facilities. Explosive demand growth has accompanied the massive AI infrastructure expansion, driving requirements for ultra-high-speed data connectivity solutions. This favorable environment has fueled AXT’s remarkable valuation expansion throughout the past year.
The company’s product portfolio also encompasses gallium arsenide and germanium wafers, targeting diverse applications spanning 5G networks, LED illumination systems, laser technologies, sensor equipment, and satellite photovoltaic cells. Manufacturing operations are concentrated in China, where AXT maintains three production facilities and holds minority ownership positions in ten raw material supply partners.
Notwithstanding the impressive stock appreciation, AXT’s financial statements reveal a business still progressing toward sustained profitability. Management’s first quarter revenue guidance calls for $26 million to $28 million, representing improvement from the prior-year period’s $19.4 million. Nevertheless, the company projects a quarterly net loss ranging from $1.6 million to $2.6 million.
Examining Current Valuation Metrics
Based on Monday’s closing price, AXT commanded a forward price-to-earnings multiple approaching 535 times. Such an elevated valuation places substantial pressure on operational performance. Any indication of decelerating growth momentum or persistent profitability challenges could trigger significant price adjustments.
The most current Wall Street analyst recommendation assigns a Buy rating with a $90 price objective.
The equity offering was disclosed after Monday’s market close, triggering the swift premarket response observed Tuesday morning.
